The Effect of Temozolomide Dose and Erythropoietin Combination On Survivin Gene Expression in Human Glioblastoma Cell Lines

Journal Title: Journal of Neurological Sciences-Turkish - Year 2012, Vol 29, Issue 3

Abstract

Glioblastoma (GBM) is an aggressive primary brain tumor and it is known that prognosis is poor. Because of the infiltration of the tumor cells to the whole brain tissue, surgery is done for decompression and for histopathological diagnosis. Radiotherapy is mandatory after surgery but survival period is not sufficient. In recent years there are many researches for chemotherapeutical agents to use for treatment of GBM but most of the results of the researches are controversial. Temozolomide (TMZ) is a new agent which is effective in prolonging survival of GBM patients. Erythropoietin promotes red blood cell maturation and used to prevent or treat anemia. It is also known that EPO has neuroprotective effect. In this study we used GMS-10 human glioblastoma cell lines. We applied TMZ with different doses and TMZ + EPO combination to check the efficacy on the survivin gene expression in human glioblastoma cell lines. As a result we observed that increasing the dose of TMZ and combination with EPO results over expression of survivin gene which means drug resistance.

Authors and Affiliations

Arif Osun, Zubeyde Erbayraktar, Serhat Erbayraktar, Ali Samancioglu, Zeynep Zadeogullari, Serpil Akhisarlioglu, Derya Ozgun

Keywords

Related Articles

EEG Findings in Behçet’s Syndrome

Objective: To evaluate the electroencephalographic features and their relation with clinical signs in Behcet Syndrome (BS). Material and Methods: In this study, electroencephalographic records (EEG) of 40 patients (26...

Leu7Pro polymorphism of preproneuropeptide Y during a course of metabolic disease: functional analysis by gene ontology

Background and Purpose: Neuropeptide Y (NPY), one of the most abundant neuropeptides found in the central nervous system (CNS), has been implicated in the regulation of many metabolism. Preproneuropeptide Y (PPNPY) is th...

Carotid Artery Stenosis and Homocysteine in Ischemic Stroke: A case-control study

Background: Hyperhomocysteinemia, has been identified as being associated with vascular disease, including cerebrovascular disease in general. The aim of our study is based on the evaluation of the correlation between th...

Nocardiosis In an Immunocompetent Host

The culprit for Nocardiosis is an aerobic actinomycetes in the genus Nocardia, a rare gram- positive bacteria. The most common disease sites include lungs, central nervous system, and skin. CNS involvement is usually pre...

Effect of Retinoic Acid and Chemotherapeutic Agents on Untrastructural Localization of Myc-N in Neuroblastoma

The effect mechanism of pharmacological agents used in neuroblastoma treatment on myc-N expression is still unclear. Myc-N amplification does not change with any agent. The aim of this study is to investigate the effect...

Download PDF file
  • EP ID EP108893
  • DOI -
  • Views 97
  • Downloads 0

How To Cite

Arif Osun, Zubeyde Erbayraktar, Serhat Erbayraktar, Ali Samancioglu, Zeynep Zadeogullari, Serpil Akhisarlioglu, Derya Ozgun (2012). The Effect of Temozolomide Dose and Erythropoietin Combination On Survivin Gene Expression in Human Glioblastoma Cell Lines. Journal of Neurological Sciences-Turkish, 29(3), 518-526. https://www.europub.co.uk/articles/-A-108893